American biotechnology company in Cambridge, Massachusetts, founded in 2010 and listed on the Nasdaq, built around messenger RNA as a medicine platform. Develops, makes and sells mRNA vaccines, among them its COVID-19 and respiratory syncytial virus vaccines, and works on influenza, cytomegalovirus and other infectious disease vaccines, individualised cancer therapies and rare disease treatments, running its own research laboratories and manufacturing sites in the United States and abroad together with clinical development and pharmacovigilance.
Aucun commentaire disponible.
Laissez votre note & commentaire